Panel Discussion | Prevalence Impact and Management of HALT and Valve Thrombosis

Monday, March 9, 2026

2:48 PM - 3:03 PM EST

Location: Cabinet

Moderator(s)

Tarun Chakravarty, MD

Associate Professor, Interventional Cardiology
Cedars-Sinai Medical Center
Los Angeles, California, United States

Disclosure(s): Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Cedars-Sinai Medical Center: Employee (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing)
Konstantinos Marmagkiolis, MD,MBA,FACC,FSCAI

interventional, structural, and endovascular cardiologist
Heart and Vascular Institute (HVI) at Tampa General Hospital (TGH) in Tampa, FL
Wesley Chapel, Florida, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Lakshmi P. Dasi, PhD, FACC

Professor
Georgia Tech / Emory University

Disclosure information not submitted.
Eliano Navarese, MD, PhD

Head of Clinical Experimental Cardiology
University of Sassari

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Tarun Chakravarty, MD: Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing); Cedars-Sinai Medical Center: Employee (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing)

Konstantinos Marmagkiolis, MD,MBA,FACC,FSCAI: No financial relationships to disclose

Eliano Navarese, MD, PhD: No financial relationships to disclose